Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Enfusion, Inc. ENFN NYSE

NYSE • Technology • Software - Application • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Enfusion, Inc. (ENFN) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bearish — 2 Buy, 3 Hold, 3 Sell.

ENFN Analyst Ratings

Hold
8
Ratings
2 Buy
3 Hold
3 Sell
Based on 8 analysts giving stock ratings to Enfusion, Inc. in the past 3 months
Rating breakdown
Buy
2 25%
Hold
3 38%
Sell
3 38%
25%
Buy
2 analysts
38%
Hold
3 analysts
38%
Sell
3 analysts

People Also View

CWAN
CWAN
Clearwater Analytics Holdings, Inc.
$24.06
+0.04%
 CVT
CVT
Cvent Holding Corp.
$8.52
+0.00%
 PYCR
PYCR
Paycor HCM, Inc.
$22.49
+100.00%
 PWSC
PWSC
PowerSchool Holdings, Inc.
$22.81
-0.18%
 BRZE
BRZE
Braze, Inc.
$20.51
-0.49%
 FRSH
FRSH
Freshworks Inc.
$7.82
-0.89%
 BLKB
BLKB
Blackbaud, Inc.
$35.88
-0.77%
 MLNK
MLNK
MeridianLink, Inc.
$20.01
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message